(Q39642897)

13 September 2017

title

CYP3A5-mediated metabolism of midazolam in recombinant systems is highly sensitive to NADPH-cytochrome P450 reductase activity (English)

1 reference

13 September 2017

1 reference

genetic recombination

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20954901

4 August 2024

author name string

Hege Christensen

1

1 reference

13 September 2017

Espen Molden

3

1 reference

13 September 2017

Liv Mathiesen

4

1 reference

13 September 2017

Anette L. Hestad

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20954901

4 August 2024

language of work or name

English

0 references

publication date

18 October 2010

1 reference

full work available at URL

13 September 2017

http://www.tandfonline.com/doi/pdf/10.3109/00498254.2010.523734

1 reference

https://api.crossref.org/works/10.3109/00498254.2010.523734

4 August 2024

1 reference

13 September 2017

volume

41

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

1-5

1 reference

Different enzyme kinetics of midazolam in recombinant CYP3A4 microsomes from human and insect sources

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2010.523734

Enzymatic characteristics of CYP3A5 and CYP3A4: a comparison of in vitro kinetic and drug-drug interaction patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2010.523734

Effects of enzyme sources on midazolam 1'-hydroxylation activity catalyzed by recombinant cytochrome P450 3A4 in combination with NADPH-cytochrome P450 reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2010.523734

Evaluation of approach to predict the contribution of multiple cytochrome P450s in drug metabolism using relative activity factor: effects of the differences in expression levels of NADPH-cytochrome P450 reductase and cytochrome b(5) in the expressi

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2010.523734

Drug metabolism by Escherichia coli expressing human cytochromes P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2010.523734

Predicting drug clearance from recombinantly expressed CYPs: intersystem extrapolation factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2010.523734

Validation and use of cloned, expressed human drug-metabolizing enzymes in heterologous cells for analysis of drug metabolism and drug-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2010.523734

Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2010.523734

Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2010.523734

Evaluation of microsomal incubation conditions on CYP3A4-mediated metabolism of cyclosporine A by a statistical experimental design

21 January 2018

4

1 reference

https://api.crossref.org/works/10.3109/00498254.2010.523734

Drug Metabolism and Disposition

4 August 2024

5

28

246

Houston JB

2000

1 reference

https://api.crossref.org/works/10.3109/00498254.2010.523734

Drug Metabolism and Disposition

4 August 2024

10

28

1493

Venkatakrishnan K

2000

1 reference

https://api.crossref.org/works/10.3109/00498254.2010.523734

Drug Metabolism and Disposition

4 August 2024

12

27

999

Yamazaki H

1999

1 reference

https://api.crossref.org/works/10.3109/00498254.2010.523734

4 August 2024

Identifiers

1 reference

13 September 2017

1 reference